SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
QLT PhotoTherapeutics (QLTI)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1321 51 0 QLTI
Emcee:  Doug Lakin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
146 John, I wish I could help you out, but I'm not a shorter and I'm not awJAMES BORECKI-9/1/1997
145 32 days to cover short position. James, I am not a serious QLTIF owner - justJohn McCarthy-9/1/1997
144 <I own a lot of QLT also but you can't believe everything one analyst saJAMES BORECKI-8/27/1997
143 To bring Christine Charette down to earth... Charette bashed Biochem Pharma a cJarrod W. Pakosh-8/27/1997
142 >>Furthermore, after having discussions with a number of oncologists who squetch-8/27/1997
141 Speaking of Midland Walwyn.......sorry, folks, but if I was in this stock I woumarcos-8/27/1997
140 Good point, James. I don't recall who did the rating, but I have heard sevGarth Richmond-8/25/1997
139 Hi Squetch, The NB comparison was to other biotech co's in various stages oGarth Richmond-8/25/1997
138 I've owned and still own a substantial position in QLT. I must say that NesDonald Gravenor-8/22/1997
137 Thank you Helmut. Best of luck. squetchsquetch-8/22/1997
136 Helmut, these two companies should join forces...if only to ease my mind. If QJAMES BORECKI-8/22/1997
135 Helmut, Christine seems quite impressive, as strong as her picture, what a shotJAMES BORECKI-8/22/1997
134 Helmut, ODAC, is the FDA's Oncology Drugs Advisory Committee, which is a paJoe Stephenson-8/22/1997
133 This was in Thursday's Globe and Mail International Business section. &quoHelmut-8/22/1997
132 JimBo Try this address canoe.ca It's from the Financial Post Web site. AtHelmut-8/22/1997
131 squetch I think I may have the same Nesbitt-Burns analysis. The detailed compHelmut-8/22/1997
130 Garth, my broker is NB as well. I would love to know more about the actual ratJAMES BORECKI-8/21/1997
129 >>Nesbitt-Burns loves this stock and recently sent me a comparative analysquetch-8/21/1997
128 Nesbitt-Burns loves this stock and recently sent me a comparative analysis. TheGarth Richmond-8/21/1997
127 I understand that 2 of the 3 analysts who knocked QLT in the Financial Post havJAMES BORECKI-8/20/1997
126 Is it paranoid to think that some analysts deliberately try to drive down a stoHelmut-8/20/1997
125 For those interested in Photofrin's potential: see PubMed at ncbi.nlm.nih.gCindy B.-8/19/1997
124 Today's Globe and Mail did a feature on this company. Overall it indicateddon jackson-8/19/1997
123 I'm with you. Let's hope for good news in September. Good luck. HelmHelmut-8/14/1997
122 Expected loss was .09 according to first call. Our Nesbitt Burns broker has conparu-8/13/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News